Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses

Juliane Schroeder, Toni Aebischer

Research output: Contribution to journalArticlepeer-review

Abstract

Release of outer membrane vesicles is a common feature of Gram negative bacteria. There is growing interest in the use of these vesicles in the development of affordable vaccines. However, to exploit their full potential a convenient system to generate recombinant vesicles would be highly desirable. Here, we report the design of a versatile system for preparation of recombinant outer membrane vesicles based on an engineered autotransporter. Two model vaccine antigens of Leishmania were expressed as fusion proteins with the transporter domain of AIDA, the Escherichia coli adhesin involved in diffuse adhesion. Single subcutaneous injections of recombinant vesicles boosted vaccine antigen-specific antibody responses in mice primed with live recombinant salmonella vaccines by 6-40-fold. The results further show an expansion of only the vaccine antigen-specific antibody response indicating a great potential of this approach for prime boost vaccination strategies. (C) 2009 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)6748-6754
Number of pages7
JournalVaccine
Volume27
Issue number48
DOIs
Publication statusPublished - 12 Nov 2009

Fingerprint

Dive into the research topics of 'Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses'. Together they form a unique fingerprint.

Cite this